Mutant Proteins as Cancer-Specific Biomarkers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140051105A1
SERIAL NO

13980005

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Altered protein products resulting from somatic mutations are directly identified and quantified by mass spectrometry. The peptides expressed from normal and mutant alleles are detected by Selected Reaction Monitoring (SRM) of their productions using a triple quadrupole mass spectrometer. As a prototypical example of this approach, we quantify the number and fraction of mutant Ras protein present in cancer cell lines. There were an average of 1.3 million molecules of Ras protein per cell and the ratio of mutant to normal Ras proteins ranged from 0.49 to 5.6. Similarly, we detected and quantified mutant Ras proteins in clinical specimens such as colorectal and pancreatic tumor tissues as well as in pre-malignant pancreatic cyst fluids. These methods are useful for diagnostic applications.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE JOHNS HOPKINS UNIVERSITYBALTIMORE MARYLAND 21218

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kinzler, Kenneth W Baltimore, US 281 4765
Pandey, Akhilesh Ellicott city, US 7 100
Papadopoulos, Nickolas Towson, US 89 1067
Vogelstein, Bert Baltimore, US 323 6289
Wang, Qing Parkville, US 398 2404

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation